![](https://news.europawire.eu/wp-content/uploads/2020/11/EIB-signs-€15.0-million-financing-deal-with-AB-Science-to-support-the-development-of-masitinib-as-a-treatment-for-COVID-19-144x144.jpg)
Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating COVID-19 in addition to other diseases for which no therapeutic solutions are available (PRESS RELEASE) PARIS, 30-Nov-2020 — /EuropaWire/ — … Read the full press release